> Details

Schaub, Nora; Reichlin, Tobias; Meune, Christophe; Twerenbold, Raphael; Haaf, Philip; Hochholzer, Willibald; Niederhauser, Nadine; Bosshard, Piet; Stelzig, Claudia; Freese, Michael; Reiter, Miriam; Gea, Joachim; Buser, Andreas; Mebazaa, Alexandre; Osswald, Stefan; Mueller, Christian

Markers of Plaque Instability in the Early Diagnosis and Risk Stratification of Acute Myocardial Infarction

Reference
management

Bookmarks

Remove from
bookmarks

Share this on Whatsapp

Close

Bookmarks



You can manage bookmarks using lists, please log in to your user account for this.
  • Media type: E-Article
  • Title: Markers of Plaque Instability in the Early Diagnosis and Risk Stratification of Acute Myocardial Infarction
  • Contributor: Schaub, Nora; Reichlin, Tobias; Meune, Christophe; Twerenbold, Raphael; Haaf, Philip; Hochholzer, Willibald; Niederhauser, Nadine; Bosshard, Piet; Stelzig, Claudia; Freese, Michael; Reiter, Miriam; Gea, Joachim; Buser, Andreas; Mebazaa, Alexandre; Osswald, Stefan; Mueller, Christian
  • Published: Oxford University Press (OUP), 2012
  • Published in: Clinical Chemistry, 58 (2012) 1, Seite 246-256
  • Language: English
  • DOI: 10.1373/clinchem.2011.172940
  • ISSN: 0009-9147; 1530-8561
  • Origination:
  • Footnote:
  • Description: Abstract BACKGROUND Plaque erosion and plaque rupture occur early in the pathophysiology of acute myocardial infarction (AMI). We hypothesized that markers of plaque instability might be useful in the early diagnosis and risk stratification of AMI. METHODS In this multicenter study, we examined 4 markers of plaque instability, myeloperoxidase (MPO), myeloid-related protein 8/14 (MRP-8/14), pregnancy-associated plasma protein-A (PAPP-A), and C-reactive protein (CRP) in 398 consecutive patients presenting to the emergency department with acute chest pain and compared them to normal and high-sensitivity cardiac troponin T (cTnT and hs-cTnT). The final diagnosis was adjudicated by 2 independent cardiologists. Primary prognostic end point was death during a median follow-up of 27 months. RESULTS The adjudicated final diagnosis was AMI in 76 patients (19%). At emergency department presentation, concentrations of all 4 biomarkers of plaque instability were significantly higher in patients with AMI than in patients with other diagnoses. However, their diagnostic accuracy as quantified by the area under the ROC curve (AUC) was low (MPO 0.63, MRP-8/14 0.65, PAPP-A 0.62, CRP 0.59) and inferior to both normal and high-sensitivity cardiac troponin T (cTnT 0.88, hs-cTnT 0.96; P < 0.001 for all comparisons). Thirty-nine patients (10%) died during follow-up. Concentrations of MPO, MRP-8/14, and CRP were higher in nonsurvivors than in survivors and predicted all-cause mortality with moderate accuracy. CONCLUSIONS Biomarkers of plaque instability do not seem helpful in the early diagnosis of AMI but may provide some incremental value in the risk stratification of patients with acute chest pain.